- Review
-
Discussion on critical points for a tailored therapy to cure hepatitis C virus infection
-
Nadia Marascio, Angela Quirino, Giorgio Settimo Barreca, Luisa Galati, Chiara Costa, Vincenzo Pisani, Maria Mazzitelli, Giovanni Matera, Maria Carla Liberto, Alfredo Focà, Carlo Torti
-
Clin Mol Hepatol. 2019;25(1):30-36. Published online January 23, 2019
-
-
- Original Article
-
Efficacy and safety of entecavir versus lamivudine over 5 years of treatment: A randomized controlled trial in Korean patients with hepatitis B e antigen-negative chronic hepatitis B
-
Kwan Sik Lee, Young-Oh Kweon, Soon-Ho Um, Byung-Ho Kim, Young Suk Lim, Seung Woon Paik, Jeong Heo, Heon-Ju Lee, Dong Joon Kim, Tae Hun Kim, Young-Sok Lee, Kwan Soo Byun, Daeghon Kim, Myung Seok Lee, Kyungha Yu, Dong Jin Suh
-
Clin Mol Hepatol. 2017;23(4):331-339. Published online September 26, 2017
-
-
-
Clinical features and outcomes of patients with hepatocellular carcinoma complicated with bile duct invasion
-
Jihyun An, Kwang Sun Lee, Kang Mo Kim, Do Hyun Park, Sang Soo Lee, Danbi Lee, Ju Hyun Shim, Young-Suk Lim, Han Chu Lee, Young-Hwa Chung, Yung Sang Lee
-
Clin Mol Hepatol. 2017;23(2):160-169. Published online May 16, 2017
-
-
-
Immunosuppression status of liver transplant recipients with hepatitis C affects biopsy-proven acute rejection
-
Jong Man Kim, Kwang-Woong Lee, Gi-Won Song, Bo-Hyun Jung, Hae Won Lee, Nam-Joon Yi, ChoonHyuck David Kwon, Shin Hwang, Kyung-Suk Suh, Jae-Won Joh, Suk-Koo Lee, Sung-Gyu Lee
-
Clin Mol Hepatol. 2016;22(3):366-371. Published online September 25, 2016
-
-
|